PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

Clinical trial NCT07429240 · RECRUITING

Trial details

NCT number: NCT07429240
Sponsor: Precision BioSciences, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD

Start date: 2026-04-24
Primary completion: 2029-11-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.